open access

Vol 59, No 1 (2008)
Original papers
Published online: 2008-01-21
Submitted: 2013-02-15
Get Citation

The possibility of prevention of type 2 diabetes

Adam Strus, Barbara Szepietowska, Anna Zonenberg, Agnieszka Nikołajuk, Maria Górska, Małgorzata Szelachowska
Endokrynologia Polska 2008;59(1):6-12.

open access

Vol 59, No 1 (2008)
Original papers
Published online: 2008-01-21
Submitted: 2013-02-15

Abstract

Introduction: The aim of this study was to examine usefulness of oral glucose tolerance test (OGTT) in clinical evaluation of different glucose metabolism disturbances in subjects with at least one risk factor of type 2 diabetes. We compared the effectiveness of non-pharmacological and pharmacological prevention and treatment regiments on metabolic control in these individuals.
Material and methods: The study involved 130 patients, with the following characteristics: age between 18 to 76 years, mean body mass index (BMI) - 31.82 ± 7.24 kg/m2, and presence of at least one of the risk factor of type 2 diabetes. Glucose metabolism disturbances were diagnosed according to World Health Organization (WHO) criteria. Non-pharmacological regiments were applied for 3 months for patients with impaired glucose tolerance (IGT) and type 2 diabetes. Patients, whose still met criteria for type 2 diabetes during OGTT after non-pharmacological treatment were scheduled for pharmacological interventions. These patients were assigned at random to two groups, that were treated with either metformin or acarbose. The measurements of total cholesterol (TC), HDL–cholesterol , LDL-cholesterol, trigliceryde (TG), glucose, HbA1c and/or OGGT were performed during each visit. We also assessed risk factors for type 2 diabetes in these subjects.
Results: The prevalence of abnormal glucose tolerance in subjects with at least one of the risk factor of diabetes type 2 was near 40%. OGTT in these subjects increased the possibility of diagnosis diabetes type 2 and IGT. Hypertension (81%), hypercholesterolemia (71.4%), hypertriglicerydemia (71.4%) and obesity (66.7%) were the most frequent risk factors observed. There were no differences in biochemical measurements between these groups of patients.
Conclusions: Individuals with at least one risk factor of type 2 diabetes should have screening test to diagnose glucose intolerance. Both non-pharmacological and pharmacological intervention was effective in normalization of glucose OGTT in patients with diabetes type 2 and IGT in newly diagnosed with disease patients. Pol J Endocrinol 2008; 59 (1): 6-12

Abstract

Introduction: The aim of this study was to examine usefulness of oral glucose tolerance test (OGTT) in clinical evaluation of different glucose metabolism disturbances in subjects with at least one risk factor of type 2 diabetes. We compared the effectiveness of non-pharmacological and pharmacological prevention and treatment regiments on metabolic control in these individuals.
Material and methods: The study involved 130 patients, with the following characteristics: age between 18 to 76 years, mean body mass index (BMI) - 31.82 ± 7.24 kg/m2, and presence of at least one of the risk factor of type 2 diabetes. Glucose metabolism disturbances were diagnosed according to World Health Organization (WHO) criteria. Non-pharmacological regiments were applied for 3 months for patients with impaired glucose tolerance (IGT) and type 2 diabetes. Patients, whose still met criteria for type 2 diabetes during OGTT after non-pharmacological treatment were scheduled for pharmacological interventions. These patients were assigned at random to two groups, that were treated with either metformin or acarbose. The measurements of total cholesterol (TC), HDL–cholesterol , LDL-cholesterol, trigliceryde (TG), glucose, HbA1c and/or OGGT were performed during each visit. We also assessed risk factors for type 2 diabetes in these subjects.
Results: The prevalence of abnormal glucose tolerance in subjects with at least one of the risk factor of diabetes type 2 was near 40%. OGTT in these subjects increased the possibility of diagnosis diabetes type 2 and IGT. Hypertension (81%), hypercholesterolemia (71.4%), hypertriglicerydemia (71.4%) and obesity (66.7%) were the most frequent risk factors observed. There were no differences in biochemical measurements between these groups of patients.
Conclusions: Individuals with at least one risk factor of type 2 diabetes should have screening test to diagnose glucose intolerance. Both non-pharmacological and pharmacological intervention was effective in normalization of glucose OGTT in patients with diabetes type 2 and IGT in newly diagnosed with disease patients. Pol J Endocrinol 2008; 59 (1): 6-12
Get Citation

Keywords

diabetes mellitus type 2; prevention; treatment

About this article
Title

The possibility of prevention of type 2 diabetes

Journal

Endokrynologia Polska

Issue

Vol 59, No 1 (2008)

Pages

6-12

Published online

2008-01-21

Bibliographic record

Endokrynologia Polska 2008;59(1):6-12.

Keywords

diabetes mellitus type 2
prevention
treatment

Authors

Adam Strus
Barbara Szepietowska
Anna Zonenberg
Agnieszka Nikołajuk
Maria Górska
Małgorzata Szelachowska

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl